SCHEMBL14048009

SCHEMBL14048009

C=CN(CC)c1nc(C)nc(N)c1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22651230 0.75 ADORA2A (0.33) —
SCHEMBL2371337 0.65 LMNA (0.39) —
SCHEMBL10671138 0.64 SMN1; SMN2 (0.39) —
SCHEMBL9127003 0.61 SMN1; SMN2 (0.42) —
SCHEMBL7745114 0.61 KDM4E (0.39) —
SCHEMBL1830380 0.58 LMNA (0.40) —
SCHEMBL9123231 0.58 SMN1; SMN2 (0.37) —
SCHEMBL24672012 0.58 HTT (0.33) —
SCHEMBL11916225 0.57 PDE10A (0.39) —
SCHEMBL16883820 0.57 TDP1 (0.54) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1646390-B1 A1 ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-10-08 — — EP disclosed
Send feedback